BAJAJ BROKING

Notification close image
No new Notification messages
card image
Oswal Pumps IPO is Open!
Apply for the Oswal Pumps IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Influx Healthtech IPO: Things Smart Investors Need to Know

Influx Healthtech Limited, incorporated in September 2020, operates as a healthcare-focused Contract Development and Manufacturing Organization (CDMO). The company supports businesses in the nutraceutical, cosmetic, pharmaceutical, and wellness sectors by providing a complete range of services—from product development to regulatory guidance. Based in Mumbai, the company offers manufacturing solutions across multiple dosage forms, such as tablets, capsules, powders, softgels, gummies, jellies, effervescent tablets, oral films, and injectables. It also produces skincare, haircare, beard care, face masks, soaps, Ayurvedic and herbal products, veterinary feed supplements, and homecare goods.

The company manages three manufacturing units located in Thane, Maharashtra, with facility sizes of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. These facilities operate under globally recognised standards including GMP, HACCP, ISO 22000, and Halal certifications. As of June 11, 2025, Influx Healthtech employs 163 permanent staff, contributing to its operational and technical capabilities in contract manufacturing.

For more details, visit the Influx Healthtech IPO page.

Influx Healthtech IPO Details and Objectives

Details

Information

IPO Date

June 18, 2025 to June 20, 2025

Issue Size

61,00,800 shares

(aggregating up to ₹58.57 Cr)

Price Band

₹91 to ₹96 per share

Lot Size

1200 shares

Listing At

NSE SME

Purpose of the IPO

  • Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division

  • Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division

  • Purchase of Machineries for Homecare and Cosmetic Division

  • General Corporate Expenses

Timeline of Influx Healthtech IPO

Event

Date

IPO Open Date

Wed, Jun 18, 2025

IPO Close Date

Fri, Jun 20, 2025

Tentative Allotment

Mon, Jun 23, 2025

Initiation of Refunds

Tue, Jun 24, 2025

Credit of Shares to Demat

Tue, Jun 24, 2025

Tentative Listing Date

Wed, Jun 25, 2025

Cut-off time for UPI mandate confirmation

5 PM on June 20, 2025

Pricing & Lot Size of Influx Healthtech IPO

Price Band for the IPO

  • ₹91 to ₹96 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Retail (Min)

1

1200

₹1,15,200

Retail (Max)

1

1200

₹1,15,200

HNI (Min)

2

2,400

₹2,30,400

How to Apply for the Influx Healthtech IPO?

Online Application Process

  • Log in to Your Trading Account
    Access your trading account through your broker’s platform.

  • Navigate to the IPO Section
    Go to the IPO section to view active IPO listings.

  • Select Influx Healthtech IPO
    Find "Influx Healthtech IPO" and click on the ‘Apply’ button.

  • Enter Application Details
    Specify the number of lots (minimum lot size: 1200 shares) and the bid price within the range of ₹91 to ₹96 per share.

  • Provide Your UPI ID
    Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

  • Review and Submit
    Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on June 20, 2025, to complete your application process.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹28.30 crore in FY23 to ₹70.30 crore as of March 2025.

  • Revenue: Reached ₹104.99 crore in FY25.

  • Profit After Tax (PAT): Stood at ₹13.37 crore for March 2025.

  • Net Worth: Recorded at ₹36.15 crore in FY25.

  • Reserves and Surplus: Recorded at ₹18.00 crore (March 2025), growing steadily over the years.

  • Total Borrowings: Stood at ₹0.22 crore in March 2025.

Recent Performance and Growth Prospects

  • The company has shown a consistent rise in its total assets over recent financial years, indicating expansion in operations and investments.

  • Revenue has progressed steadily, reflecting increased demand for the company’s manufacturing and development services.

  • Profit levels have improved, suggesting effective cost management and enhanced operational efficiency.

  • The company’s net worth has grown over time, highlighting financial stability and retained value generation.

  • Reserves and surplus have seen a positive trend, pointing to strengthened internal financial support and reinvestment capacity.

  • The borrowing levels remain minimal, suggesting reliance on internal accruals and controlled financial leverage.

  • These indicators collectively suggest a company with growing operational capacity and an improving financial position, with potential to support further expansion in the healthcare manufacturing sector.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company operates in a highly regulated industry, where changes in compliance norms, licensing requirements, or safety standards could affect its operations and costs.

  • Dependence on a specific segment such as nutraceuticals or cosmetics may expose the business to sector-specific slowdowns or demand fluctuations.

Opportunities and Growth Potential

  • Expansion into new manufacturing divisions—nutraceuticals, veterinary food, homecare, and cosmetics—indicates a forward-looking strategy aimed at broadening its client base and operational capacity.

  • The company’s integrated model, from product development to regulatory support, allows it to serve a range of industries and adapt its offerings as market needs evolve.

Key Performance Indicator (KPI)

KPI

Values

ROE

36.98%

ROCE

49.17%

Debt/Equity

0.01

RoNW

36.98%

PAT Margin

12.75

Price to Book Value

7.62

 

Influx Healthtech IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Maashitla Securities Private Limited

Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd.

Company Address of Influx Healthtech Ltd

Influx Healthtech Limited

109, Ghanshyam Enclave Premises Co-op

Soc Plot No. 856, Laljipada

Kandivali West,

Mumbai, Maharashtra, 400067

Phone: +91 7045997809

Email: cs@influxhealthtech.com

Conclusion

Influx Healthtech Limited operates across multiple sectors within the healthcare and wellness manufacturing space. With its base in Mumbai and manufacturing units in Thane, the company offers a range of services covering product development, regulatory support, and contract manufacturing for various dosage forms and personal care segments.

The upcoming IPO is structured to support capital expenditure and operational expansion across different divisions. Interested participants may review the IPO details, objectives, and timelines to understand the offering in its current context.

Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Influx Healthtech IPO. 

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|